“ The aim is not to be the “start-up nation”, but to be able to build world leaders in France in the sectors of the future. And that remains to be proven. ! “launches Philippe Poulettyfounder of Truffle Capital. This medical doctor and serial entrepreneur, who spent thirteen years in Silicon Valley, evaluates 500 patent applications a year from the top 50 American and European universities, with the aim of turning the most promising into a company.

His focus is on creating companies that address global issues such as obesity, stroke, but also the climate challenge. “ We can lift up to a maximum of 100 million in France for a good medtech, biotech or technology company, but beyond that, it becomes difficult. “he explained on Le Figaro TV’s Esprit d’Entreprise program.

Read also
Kyutai: one year on, Xavier Niel’s “AI Avengers” make their voices heard

Numerous…